Skip to main content
logo
Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
18.86
-0.13 (-0.68%)
Aug 10, 2026, 4:00 PM EDT - Market closed

AAPG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,7042,449----
Market Cap Growth
-55.80%-----
Enterprise Value
1,6352,3800000
Last Close Price
18.8626.24----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
20.7629.84----
PB Ratio
8.9312.94----
P/TBV Ratio
1.361.89----

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.9229.01----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.570.573.2416.693.120.84
Net Debt / Equity Ratio
-0.37-0.371.5411.620.74-0.53
Net Debt / EBITDA Ratio
0.410.41-1.38-0.87-0.360.69
Net Debt / FCF Ratio
0.410.41-3.00-0.91-0.350.64
Asset Turnover
0.170.170.380.080.070.01
Inventory Turnover
2.782.782.562.383.291.69
Quick Ratio
1.661.661.151.331.764.98
Current Ratio
1.791.791.261.441.865.22
Return on Equity (ROE)
-73.47%-154.56%-235.32%-386.28%-107.45%-75.18%
Return on Assets (ROA)
-39.54%-39.29%-15.56%-33.40%-31.08%-39.59%
Return on Invested Capital (ROIC)
-154.18%-169.54%-54.77%-120.19%-139.65%-199.47%
Return on Capital Employed (ROCE)
-68.19%-68.19%-25.71%-51.04%-39.80%-48.77%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
Total Shareholder Return
-17.90%-17.90%-7.00%-7.06%-3.56%-17.93%
SEC Filings: 10-K · 10-Q